1201784-90-8 Usage
General Description
6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol is a chemical compound with the molecular formula C6H3BrN4O2. It is a heterocyclic compound that contains a pyrrolo-triazine ring system and two hydroxyl groups. This chemical has potential applications in the field of medicinal chemistry and pharmaceutical research due to its unique structure and potential biological activities. It may also be used in the synthesis of other organic compounds and in the development of new materials. Additionally, it may have potential applications in the field of agricultural chemistry as well. Overall, 6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol is a versatile chemical compound with interesting potential applications across various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1201784-90-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,7,8 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1201784-90:
(9*1)+(8*2)+(7*0)+(6*1)+(5*7)+(4*8)+(3*4)+(2*9)+(1*0)=128
128 % 10 = 8
So 1201784-90-8 is a valid CAS Registry Number.
1201784-90-8Relevant articles and documents
CDK kinase inhibitors
-
, (2020/12/30)
The invention discloses a compound with the general formula (I) and a salt thereof, wherein the compound can be taken as inhibitors of CDK kinase, particularly CDK4/6 kinase, and all variables are defined in the invention. The compound can be used for treating or preventing diseases such as cancer. The present application also relates to pharmaceutical compositions comprising the compound of formula (I).
TGF BETA RECEPTOR ANTAGONISTS
-
Page/Page column 151; 152; 153, (2017/03/08)
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβ R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.